Diabetic retinopathy is one of the leading causes of vision loss and blindness around the globe, and affects approximately one-third of people with diabetes.
Diabetes impairs the body’s ability to control blood sugar. Because sugar can promote inflammation, a person with diabetes may experience inflammatory damage to various tissues within their body, including the retina, which is located on the inside back of your eye. High blood sugar causes damage to the blood vessels in the retina as these small vessels may become leaky and irritated. . Over time, this can lead to complete vision loss if not treated properly.
Optomap is specifically designed to provide an ultra-widefield image of the retina, and it is the only technology that captures a 200 degree image of the retina in a single scan and in less than ½-second. Because Optomap can image so far out in the periphery, where the damage from diabetic retinopathy often begins, it allows eyecare professionals to get a clear view of the health of the retina and determine if there are any early warning signs of diabetic retinopathy. Optomap can also be used to confirm a diagnosis, allowing eyecare professionals to initiate a plan of care as soon as possible.